Oral metronomic cyclophosphamide in elderly with metastatic melanoma

Author： Borne Estelle   Desmedt Eve   Duhamel Alain   Mirabel Xavier   Dziwniel Véronique   Maire Cyril   Florin Valérie   Martinot Véronique   Penel Nicolas   Vercambre-Darras Sophie   Mortier Laurent  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.28, Iss.5, 2010-10, pp. : 684-689

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3923-3931

Blackwell Publishing

Access to resources Recommend Favorite

Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

By  

Clinical Cancer Drugs, Vol. 1, Iss. 2, 2014-05 ,pp. : 116-126

Bentham Science Publishers

Access to resources Recommend Favorite

Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy

By  

Clinical Cancer Drugs, Vol. 1, Iss. 2, 2014-05 ,pp. : 116-126

Bentham Science Publishers

Access to resources Recommend Favorite

A Role of Immunotherapy in Metastatic Malignant Melanoma

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclophosphamide: Leucopenia in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite